Cardlytics Inc share price today

(CDLX)

Cardlytics Inc share price is $3.83 & ₹324.52 as on 6 Dec 2024, 2.30 'hrs' IST

$3.83

▲

0.01

(0.26%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Cardlytics Inc share price in Dollar and Rupees. Guide to invest in Cardlytics Inc from India. Also see the sentimental analysis on Indian investors investing in Cardlytics Inc. Get details on the Indian mutual funds that are investing in Cardlytics Inc. Get Analyst recommendations and forecasts along with all the Cardlytics Inc's financials.

Cardlytics Inc share price movements

$3.79
$3.97
$3.83
1.04%
Downside
Day's Volatility :4.53%
Upside
3.53%
$2.89
$20.52
$3.83
24.54%
Downside
52 Weeks Volatility :85.92%
Upside
81.34%

Cardlytics Inc Returns

Period	Cardlytics Inc	Sector (Communication Services)	Index (Russel 2000)
3 Months	19.24%	16.0%	0.0%
6 Months	-53.1%	16.8%	0.0%
1 Year	-49.51%	44.0%	0.0%
3 Years	-94.16%	32.8%	-18.1%

Cardlytics Inc Key Statistics

in dollars & INR

Previous Close	$3.82
Open	$3.84
Today's High	$3.97
Today's Low	$3.79
Market Capitalization	$206.8M
Today's Volume	$995.4K
52 Week High	$20.52
52 Week Low	$2.8901
Revenue TTM	$293.5M
EBITDA	$-36.6M
Earnings Per Share (EPS)	$-6.4
Profit Margin	-93.55%
Quarterly Earnings Growth YOY	-0.57%
Return On Equity TTM	-186.12%

How to invest in Cardlytics Inc from India?

It is very easy for Indian residents to invest directly in Cardlytics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cardlytics Inc stock in both rupees (INR) and dollars (USD). Search for Cardlytics Inc or CDLX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cardlytics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cardlytics Inc shares which would translate to 0.221 fractional shares of Cardlytics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Cardlytics Inc

54%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Cardlytics Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 54% more investors are searching Cardlytics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Cardlytics Inc

BlackRock Inc
6.20%
Vanguard Group Inc
5.25%
683 Capital Management LLC
4.38%
KPS Global Asset Management UK Ltd
2.40%
Worldly Partners Management LLC
2.28%
Brightlight Capital Management LLC
2.10%

Analyst Recommendation on Cardlytics Inc

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Cardlytics Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cardlytics Inc

What analysts predicted

Upside of 14.88%

Current:

$3.83

Target:

$4.40

Insights on Cardlytics Inc

Decreasing Revenue
Revenue is down for the last 2 quarters, 69.63M → 67.05M (in $), with an average decrease of 3.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -4.25M → -145.18M (in $), with an average decrease of 3310.4% per quarter
Vs MGNI
In the last 1 year, Magnite Inc. has given 109.3% return, outperforming this stock by 159.3%
Vs OMC
In the last 3 years, Omnicom Group Inc. has given 1.8% return, outperforming this stock by 95.2%

Cardlytics Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$150.7M	↑ 15.59%
Net Income	$-53.0M	↑ 170.06%
Net Profit Margin	-35.2%	↓ 20.13%

	FY19	Y/Y Change
Revenue	$210.4M	↑ 39.65%
Net Income	$-17.7M	↓ 66.65%
Net Profit Margin	-8.41%	↑ 26.79%

	FY20	Y/Y Change
Revenue	$186.9M	↓ 11.19%
Net Income	$-58.5M	↑ 230.49%
Net Profit Margin	-31.29%	↓ 22.88%

	FY21	Y/Y Change
Revenue	$267.1M	↑ 42.93%
Net Income	$-128.6M	↑ 119.88%
Net Profit Margin	-48.13%	↓ 16.84%

	FY22	Y/Y Change
Revenue	$298.5M	↑ 11.76%
Net Income	$-465.3M	↑ 261.89%
Net Profit Margin	-155.85%	↓ 107.72%

	FY23	Y/Y Change
Revenue	$309.2M	↑ 3.57%
Net Income	$-134.7M	↓ 71.05%
Net Profit Margin	-43.56%	↑ 112.29%

	Q2 FY23	Q/Q Change
Revenue	$76.7M	↑ 12.92%
Net Income	$-23.5M	↓ 171.15%
Net Profit Margin	-30.65%	↓ 79.29%

	Q3 FY23	Q/Q Change
Revenue	$79.0M	↑ 3.0%
Net Income	$-24.0M	↑ 1.95%
Net Profit Margin	-30.33%	↑ 0.32%

	Q4 FY23	Q/Q Change
Revenue	$89.2M	↑ 12.86%
Net Income	$-100.8M	↑ 320.75%
Net Profit Margin	-113.09%	↓ 82.76%

	Q1 FY24	Q/Q Change
Revenue	$67.6M	↓ 24.18%
Net Income	$-24.3M	↓ 75.93%
Net Profit Margin	-35.91%	↑ 77.18%

	Q2 FY24	Q/Q Change
Revenue	$69.6M	↑ 3.0%
Net Income	$-4.3M	↓ 82.46%
Net Profit Margin	-6.11%	↑ 29.8%

	Q3 FY24	Q/Q Change
Revenue	$67.1M	↓ 3.7%
Net Income	$-145.2M	↑ 3310.43%
Net Profit Margin	-216.51%	↓ 210.4%

	FY18	Y/Y Change
Total Assets	$153.8M	↑ 52.61%
Total Liabilities	$101.8M	↓ 67.11%

	FY19	Y/Y Change
Total Assets	$224.3M	↑ 45.88%
Total Liabilities	$81.0M	↓ 20.38%

	FY20	Y/Y Change
Total Assets	$422.5M	↑ 88.37%
Total Liabilities	$265.3M	↑ 227.4%

	FY21	Y/Y Change
Total Assets	$1.3B	↑ 199.1%
Total Liabilities	$573.1M	↑ 115.98%

	FY22	Y/Y Change
Total Assets	$691.2M	↓ 45.3%
Total Liabilities	$479.6M	↓ 16.31%

	FY23	Y/Y Change
Total Assets	$574.1M	↓ 16.94%
Total Liabilities	$439.3M	↓ 8.4%

	Q2 FY23	Q/Q Change
Total Assets	$633.3M	↓ 7.49%
Total Liabilities	$397.2M	↓ 12.17%

	Q3 FY23	Q/Q Change
Total Assets	$634.9M	↑ 0.25%
Total Liabilities	$409.6M	↑ 3.11%

	Q4 FY23	Q/Q Change
Total Assets	$574.1M	↓ 9.57%
Total Liabilities	$439.3M	↑ 7.27%

	Q1 FY24	Q/Q Change
Total Assets	$569.0M	↓ 0.9%
Total Liabilities	$369.8M	↓ 15.83%

	Q2 FY24	Q/Q Change
Total Assets	$534.4M	↓ 6.08%
Total Liabilities	$324.3M	↓ 12.3%

	Q3 FY24	Q/Q Change
Total Assets	$399.4M	↓ 25.26%
Total Liabilities	$329.7M	↑ 1.65%

	FY18	Y/Y Change
Operating Cash Flow	$-19.0M	↓ 14.06%
Investing Cash Flow	$-7.3M	↑ 345.78%
Financing Cash Flow	$65.2M	↑ 199.58%

	FY19	Y/Y Change
Operating Cash Flow	$11.5M	↓ 160.32%
Investing Cash Flow	$-11.0M	↑ 50.1%
Financing Cash Flow	$44.2M	↓ 32.23%

	FY20	Y/Y Change
Operating Cash Flow	$-7.6M	↓ 166.32%
Investing Cash Flow	$-10.1M	↓ 8.19%
Financing Cash Flow	$206.4M	↑ 367.26%

	FY21	Y/Y Change
Operating Cash Flow	$-38.5M	↑ 407.02%
Investing Cash Flow	$-506.7M	↑ 4908.35%
Financing Cash Flow	$486.0M	↑ 135.43%

	FY22	Y/Y Change
Operating Cash Flow	$-53.9M	↑ 39.93%
Investing Cash Flow	$-15.8M	↓ 96.89%
Financing Cash Flow	$-40.0M	↓ 108.23%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$5.8M	↓ 157.14%
Investing Cash Flow	$-2.7M	↓ 1.96%
Financing Cash Flow	$-50.1M	↓ 267.03%

Cardlytics Inc Technicals Summary

Sell

Neutral

Buy

Cardlytics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cardlytics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cardlytics Inc	-21.5%	-53.1%	-49.51%	-94.16%	-93.09%
Ziff Davis Inc	26.24%	6.14%	-4.96%	-46.26%	-52.07%
Magnite Inc.	37.52%	32.95%	110.15%	-4.98%	117.32%
Omnicom Group Inc.	1.77%	15.28%	27.9%	50.27%	26.49%
Criteo Sa	17.1%	6.69%	65.0%	-3.32%	134.73%
Interpublic Group Of Companies, Inc.	1.18%	-1.95%	-2.3%	-14.99%	34.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cardlytics Inc	NA	NA	NA	-0.63	-1.86	-0.08	NA	1.38
Ziff Davis Inc	43.92	43.92	0.84	6.65	0.04	0.04	NA	41.0
Magnite Inc.	129.15	129.15	NA	0.76	0.03	0.01	NA	5.14
Omnicom Group Inc.	14.32	14.32	1.56	8.05	0.34	0.05	0.03	20.25
Criteo Sa	23.85	23.85	0.89	4.18	0.1	0.05	NA	19.19
Interpublic Group Of Companies, Inc.	14.53	14.53	163.93	2.82	0.22	0.05	0.04	10.0

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cardlytics Inc	Buy	$206.8M	-93.09%	NA	-93.55%
Ziff Davis Inc	Buy	$2.5B	-52.07%	43.92	4.53%
Magnite Inc.	Buy	$2.4B	117.32%	129.15	2.62%
Omnicom Group Inc.	Buy	$20.4B	26.49%	14.32	9.45%
Criteo Sa	Buy	$2.3B	134.73%	23.85	5.21%
Interpublic Group Of Companies, Inc.	Buy	$11.5B	34.52%	14.53	8.65%

About Cardlytics Inc

cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. we partner with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. in turn, we have a secure view into where and when consumers are spending their money. we use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. at cardlytics, we are analysts, developers, and data scientists. we are marketers, account managers, and consultants to our clients. we are all focused on making sense of the data we see to make it informative and actionable for our partners. headquartered in atlanta, ga, with offices in new york city, london, san francisco, and chicago, our team rallies around a common desire to win and to help our clients win. we are focused on building a revolutionizing company, but we still care about each other

Organization	Cardlytics Inc
Employees	456
CEO	Mr. Amit Gupta
Industry	Technology Services

Management People of Cardlytics Inc

Name	Title
Mr. Amit Gupta	CEO & Director
Ms. Alexis DeSieno	Chief Financial Officer
Mr. Nick Lynton	Chief Legal & Privacy Officer and Secretary
Mr. Peter Chan	Chief Technology Officer
Ms. Carson Napps	Chief People Officer
Mr. Jose Singer	Chief Product Officer
Ms. Evelyne Forester	Chief Business Officer

Important FAQs about investing in Cardlytics Inc from India :

What is Cardlytics Inc share price today?

Cardlytics Inc (CDLX) share price today is $3.83.

Can Indians buy Cardlytics Inc shares?

Yes, Indians can invest in the Cardlytics Inc (CDLX) from India.

With INDmoney, you can buy Cardlytics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cardlytics Inc at zero transaction cost.

How can I buy Cardlytics Inc shares from India?

It is very easy to buy Cardlytics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cardlytics Inc be purchased?

Yes, you can buy fractional shares of Cardlytics Inc with INDmoney app.

What are the documents required to start investing in Cardlytics Inc stocks?

To start investing in Cardlytics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.